Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
GAB Consultancy has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top 10 Regulatory and Compliance Companies - 2022,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with Wesley E. Brower, Vice President.
Wesley E. Brower, Vice President
Company
GAB Consultancy
Management
Wesley E. Brower, Vice President
Description
GAB Consultancy guides medical device manufacturers and OEMs to simplify their audit processes and shorten their ISO certification timeline. GAB Consultancy starts its partner engagement with both a gap analysis and a preliminary internal audit to assess the client’s specific roadblocks in attaining compliance to the requirements of various ISO standards. GAB Consultancy then develops the initial quality management system documentation by incorporating all the policies, processes, and procedures following alignment with ISO requirements, and in alignment with their existing workflows. At this time GAB Consultancy additionally generates the organization’s quality manual which serves as a top-level document outlining the ISO compliant quality management system.
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
